UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Completed
Unique ID issued by UMIN UMIN000035882
Receipt No. R000040824
Scientific Title Effect of saffron foods for quality of sleep on healthy human
Date of disclosure of the study information 2020/02/14
Last modified on 2020/01/31

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Effect of saffron foods for quality of sleep on healthy human
Acronym Effect of test foods for quality of sleep on healthy human
Scientific Title Effect of saffron foods for quality of sleep on healthy human
Scientific Title:Acronym Effect of test foods for quality of sleep on healthy human
Region
Japan

Condition
Condition healthy adults
Classification by specialty
Adult
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To evaluate the efficacy of foods containing fermented saffron on reduction in stress and quality of sleep of healthy Japanese
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes sleep electroencephalogram
Key secondary outcomes OSA questionnaire
PSQI questionnaire
VAS

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Cluster
Blinding Double blind -all involved are blinded
Control Placebo
Stratification YES
Dynamic allocation NO
Institution consideration Institution is not considered as adjustment factor.
Blocking YES
Concealment No need to know

Intervention
No. of arms 2
Purpose of intervention Prevention
Type of intervention
Food
Interventions/Control_1 saffron foods
Interventions/Control_2 Placebo foods
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
65 years-old >
Gender Male and Female
Key inclusion criteria (1) Those who are aware of mild sleep disorders, mainly employees of desk work, such as tired, poor sleep, and shallow sleep
(2) Those who sleep (turn off) time and wake-up time are regular, sleeping (lights off) time is around 24 o'clock before, and those who have sleeping habits more than 4 hours a day
(3) Those working on a 5-day weekly work day during the day and two days off on weekdays
(4) Those who sleep alone on bedding
(5) Person who obtains consent of voluntary participation in participation by document
(6) Person who the doctor responsible for examination (or person responsible for conducting the examination) deems appropriate participation in this examination
Key exclusion criteria (1) SAS suspected, treated, treated
(2) nocturia, benign prostatic hyperplasia, person with overactive bladder, or a person suspected of having it
(3) BMIis 25.0 or more
(4) Night shift and day shift worker
(5) Those who are likely to cause skin irritation due to electrode adhesive pads (such as causing skin inflammation with bandages etc)
(6) Those receiving treatment (hormone replacement therapy, medication therapy, exercise therapy, diet therapy, etc.) at a medical institution or the like for treatment or prevention of diseases at the time of acquiring consent, or a condition requiring treatment Those judged
(7) Person who has a history of serious diseases or psychiatric diseases of glucose metabolism, lipid metabolism, liver function, renal function, heart, circulatory organ, respiratory organs, endocrine system, immune system, nervous system
(8) Persons who have history of alcohol anddrug dependence
(9) Persons whose daily alcohol consumption exceeds 60 g / day in terms of average alcohol equivalent per day
(10) Persons who have drinking habits more than 4 days a week, or who can not drink alcohol on the day of electroencephalograph insertion
(11) Those who are allergic to the test foods, or those who may cause severe allergic symptoms in other foods and medicines
(12) Persons who are taking health foods described as "saffron", which is a component involved in this test food
(13) Those who participate in other human tests (all tests for humans using cosmetics, foods, medicines, quasi-drugs, medical devices, etc.) within the past 4 weeks, Those who plan to participate in other human examinations during the scheduled period
(14) Person who judges that the examination responsible doctor (or person responsible for conducting the examination) is inappropriate for participating in the examination
Target sample size 52

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name Ryuji Takeda
Organization Kansai University of welfare Sciences
Division name Faculty of Health Science for Welfare, Department of Nutritional Sciences for Well-being
Zip code
Address Asahigaoka 3-11-1, Kashiwara
TEL 0729780088
Email rtakeda@tamateyama.ac.jp

Public contact
Name of contact person
1st name
Middle name
Last name Ryuji Takeda
Organization Kansai University of Welfare Sciences
Division name Faculty of Health Science for Welfare, Department of Nutritional Sciences for Well-being
Zip code
Address Asahigaoka 3-11-1, Kashiwara
TEL 072-978-0088
Homepage URL
Email rtakeda@tamateyama.ac.jp

Sponsor
Institute DRC Co., Ltd.
Institute
Department

Funding Source
Organization Seikatsu Sougou Service Co., Ltd.
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2020 Year 02 Month 14 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2019 Year 02 Month 01 Day
Date of IRB
2019 Year 01 Month 31 Day
Anticipated trial start date
2019 Year 02 Month 16 Day
Last follow-up date
2019 Year 03 Month 24 Day
Date of closure to data entry
2019 Year 03 Month 24 Day
Date trial data considered complete
2019 Year 05 Month 01 Day
Date analysis concluded
2019 Year 08 Month 31 Day

Other
Other related information

Management information
Registered date
2019 Year 02 Month 15 Day
Last modified on
2020 Year 01 Month 31 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040824

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.